Gilead Sciences (GILD) Profit Margin (2008 - 2026)
Gilead Sciences (GILD) profit margin from Jun 30, 2008 to Mar 31, 2026. The current Gilead Sciences (GILD) profit margin is 29.04%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Gilead Sciences (GILD)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 28.90% | +1631.43% |
| 2024 | 1.67% | -92.01% |
| 2023 | 20.89% | +24.12% |
| 2022 | 16.83% | -26.17% |
| 2021 | 22.80% | +4476.10% |
| 2020 | 0.50% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 23.99% | -215.41% |
| 2019 | -20.79% | -162.86% |
| 2019 | 33.07% | -11.57% |
| 2019 | 37.40% | +51.70% |
| 2018 | 24.65% | -34.21% |
| 2018 | 37.47% | +16.48% |
| 2018 | 32.17% | +6.43% |
| 2018 | 30.23% | +70.52% |
| 2017 | 17.73% | -57.53% |
| 2017 | 41.74% | -3.01% |
| 2017 | 43.03% | +3.60% |
| 2017 | 41.54% | -6.50% |
| 2016 | 44.43% | +0.06% |
| 2016 | 44.40% | -1.27% |
| 2016 | 44.97% | -1.71% |
| 2016 | 45.75% | -17.53% |
| 2015 | 55.48% | +0.04% |
| 2015 | 55.46% | +1.77% |
| 2015 | 54.49% | -4.50% |
| 2015 | 57.06% | +17.36% |
| 2014 | 48.62% | +7.56% |
| 2014 | 45.20% | -19.21% |
| 2014 | 55.94% | +25.58% |
| 2014 | 44.55% | +62.29% |
| 2013 | 27.45% | -3.18% |
| 2013 | 28.35% | +1.48% |
| 2013 | 27.94% | -2.03% |
| 2013 | 28.52% | +6.73% |
| 2012 | 26.72% | -4.03% |
| 2012 | 27.84% | -5.90% |
| 2012 | 29.58% | +52.78% |
| 2012 | 19.36% | -42.09% |
| 2011 | 33.43% | -3.82% |
| 2011 | 34.76% | -0.44% |
| 2011 | 34.92% | +3.28% |
| 2011 | 33.81% | -7.37% |
| 2010 | 36.50% | +0.33% |
| 2010 | 36.38% | -1.54% |
| 2010 | 36.95% | -9.85% |
| 2010 | 40.99% | +9.03% |
| 2009 | 37.59% | +0.62% |
| 2009 | 37.36% | +7.70% |
| 2009 | 34.69% | -9.88% |
| 2009 | 38.49% | +3.79% |
| 2008 | 37.09% | -1.01% |
| 2007 | 37.47% | N/A |
Comparison Gilead Sciences (GILD) profit margin with competitors
Gilead Sciences (GILD) profit margin is 29.04%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +72.71% |
| LLY | Lilly(Eli) & Company | 37.36% | +28.66% |
| NVS | Novartis AG | 23.34% | -19.62% |
| BMY | Bristol-Myers Squibb Company | 23.30% | -19.76% |
| GSK | GSK Plc | 22.77% | -21.58% |
| JNJ | Johnson & Johnson | 21.76% | -25.06% |
| AMGN | AMGEN Inc | 21.11% | -27.30% |
| AZN | Astrazeneca plc | 20.15% | -30.61% |
| PFE | Pfizer Inc | 18.59% | -35.98% |
| SNY | Sanofi | 14.35% | -50.58% |
| BIIB | Biogen Inc | 12.89% | -55.61% |
| OGN | Organon & Company | 10.00% | -65.56% |
| ABBV | Abbvie Inc | 4.63% | -84.06% |
| GRFS | Grifols SA | 4.29% | -85.23% |